• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors

    12/11/23 9:00:00 AM ET
    $HNST
    $LUNG
    Catalog/Specialty Distribution
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care
    Get the next $HNST alert in real time by email

    LOS ANGELES, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care, today announced that Michael Barkley, Former Chief Executive Officer of Kind LLC, Alissa Hsu Lynch, Former Global Head of MedTech Strategy and Solutions for Google Cloud, and Andrea Turner, Former Senior Vice President, Global Customer Service & Logistics at Mondelēz International, Inc., have been appointed to its Board of Directors effective December 8, 2023.

    "We are pleased to welcome Michael, Alissa and Andrea to our board of directors. All three leaders are proven experts in the consumer goods space. Their retail and digital expertise will strengthen our board by adding significant capabilities that support the company's growth plans." said Carla Vernón, CEO of The Honest Company. "I look forward to partnering with our entire board as we continue to advance our Transformation Initiative and long-term strategy in 2024."

    Barkley, a seasoned consumer products executive, most recently served as the CEO of KIND LLC. At KIND, Barkley led the business through a new era of growth and expansion. He also spearheaded transformational change and performance acceleration at Pinnacle Foods and Johnson & Johnson. Barkley is a visionary leader who builds organizational capabilities to enable high-performing teams and deliver enduring value creation.

    Lynch is an experienced industry leader across consumer products, healthcare, and technology. At Google, she worked with Fortune 500 companies to drive digital transformation in healthcare using data, analytics, and AI. Previously, she was Vice President at Johnson & Johnson, where she held P&L and strategy roles leading billion-dollar global businesses in the MedTech and Consumer Health sectors, including Baby and Skin Care. She currently serves on the Board of Directors of Pulmonx (NASDAQ:LUNG).

    Turner, a global leader in supply chain and logistics management has a successful background which includes transformational impact at Fortune 500 companies across consumer goods, biotech and pharmaceuticals. As Senior Vice President, Global Customer Service and Logistics at Mondelēz, she strategized and led logistics during the COVID-19 pandemic for the $25 billion supply chain across 80 countries. Turner was also responsible for driving teams to solve complex supply chain problems at General Mills and Merck, delivering improved productivity and accelerating growth.

    "Honest continues to drive strong performance and demonstrate the power of our brand. As we continue on this journey to drive stakeholder value, we welcome Michael, Alissa and Andrea's expertise. They join Honest during an exciting and pivotal time for the brand and I am confident these additions further transform the board as the company evolves our growth strategy," said James D. White, Chair of the Board of The Honest Company. "Their diverse backgrounds and areas of expertise will help elevate us to new heights for consumers and push our thinking even further."

    Forward-Looking Statements

    All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will" or "would" or the negative of these words or other similar terms or expressions. These forward-looking statements include, but are not limited to, statements concerning the Company's performance and brand and the Company's ability to deliver on its Transformation Initiative and drive stakeholder value. You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this press release primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled "Risk Factors" in the Annual Report, on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 16, 2023, and Quarterly Report on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023 and September 30, 2023, respectively, filed with the Securities and Exchange Commission on May 9, 2023, August 8, 2023 and November 8, 2023, respectively, and subsequent filings with the Securities and Exchange Commission. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this press release or the earnings call referencing this press release. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

    About The Honest Company

    The Honest Company (NASDAQ:HNST) is a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care. Honest products are available via Honest.com, third-party ecommerce customers and approximately 51,000 retail locations across the United States, Canada and Europe. Based in Los Angeles, CA, the Company's mission, to inspire everyone to love living consciously, is driven by its values of transparency, trust, sustainability and a deep sense of purpose around what matters most to its consumers: their health, their families and their homes. For more information about the Honest Standard and the Company, please visit www.honest.com.

    Investor Contact:

    Elizabeth Bouquard

    ebouquard@thehonestcompany.com 

    Media Contact:

    Jennifer Kroog Rosenberg

    jrosenberg@thehonestcompany.com 



    Primary Logo

    Get the next $HNST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HNST
    $LUNG

    CompanyDatePrice TargetRatingAnalyst
    The Honest Company Inc.
    $HNST
    1/16/2026Overweight → Underweight
    Analyst
    The Honest Company Inc.
    $HNST
    11/6/2025$3.00Buy → Hold
    Lake Street
    The Honest Company Inc.
    $HNST
    11/6/2025$6.00 → $3.00Market Perform
    Telsey Advisory Group
    The Honest Company Inc.
    $HNST
    8/7/2025$7.00 → $6.00Market Perform
    Telsey Advisory Group
    Pulmonx Corporation
    $LUNG
    7/31/2025$2.50Overweight → Neutral
    Piper Sandler
    Pulmonx Corporation
    $LUNG
    3/10/2025$17.00Buy
    D. Boral Capital
    The Honest Company Inc.
    $HNST
    1/10/2025$6.00 → $7.00Market Perform
    Telsey Advisory Group
    The Honest Company Inc.
    $HNST
    12/17/2024$7.00Buy → Hold
    Loop Capital
    More analyst ratings

    $HNST
    $LUNG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) (the "Company" or "Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that on June 1, 2026 (the "Grant Date"), Pulmonx granted equity awards under its 2025 Inducement Plan (the "Inducement Plan") to 17 individuals hired by Pulmonx in the first two quarters of 2026. The awards were approved by the Compensation Committee of the Company's Board of Directors and were granted as an inducement material to the new employees entering into employment with Pulmonx, in accordance with Nasdaq Listing Rule 5635(c)(4). Each award is subject to the terms and conditions of t

    6/1/26 4:05:00 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    Honest Invites Women to Get Honest About "Down There" Conversations and Provides Solution

    Backed by new survey data, Honest aims to normalize real conversations amongst women around body realities and self-care. New survey data shows that when women discuss bathroom habits, they are twice as likely to feel a sense of connection than embarrassment.Honest empowers women to talk about taboo "down there" topics, offering Honest Flushable Wipes as the solution for feeling clean enough to get honest.SUGARED + BRONZED clients in select cities will receive a surprise & delight from Honest for a boost in confidence when baring it all this summer. Hypoallergenic and designed for sensitive skin, Honest Flushable Wipes are dermatologist tested, made with a soft plant-based cloth and over

    5/19/26 10:00:00 AM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    The Honest Company Reports First Quarter 2026 Results

    Delivers Accelerated Revenue Growth, Led by Wipes & Personal Care Achieves Record Gross Margins, Fueled by Powering Honest GrowthReaffirms Full Year 2026 Financial Outlook LOS ANGELES, May 06, 2026 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults, today reported financial results for the three months ended March 31, 2026. First Quarter 2026 Financial Highlights Compared to Prior Year Period: Revenue of $78.1 million decreased 19.7%; Organic Revenue (excluding Powering Honest Growth exits)(1) increased 3.9%Gross margin of 42.6% increased 390 basis poi

    5/6/26 4:05:00 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    $HNST
    $LUNG
    SEC Filings

    View All

    Pulmonx Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Pulmonx Corp (0001127537) (Filer)

    6/4/26 4:04:20 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    The Honest Company Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

    8-K - Honest Company, Inc. (0001530979) (Filer)

    5/27/26 4:35:39 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 10-Q filed by The Honest Company Inc.

    10-Q - Honest Company, Inc. (0001530979) (Filer)

    5/6/26 4:07:28 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    $HNST
    $LUNG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Honest Company downgraded by Analyst

    Analyst downgraded Honest Company from Overweight to Underweight

    1/16/26 8:32:37 AM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Honest Company downgraded by Lake Street with a new price target

    Lake Street downgraded Honest Company from Buy to Hold and set a new price target of $3.00

    11/6/25 7:38:39 AM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Honest Company with a new price target

    Telsey Advisory Group reiterated coverage of Honest Company with a rating of Market Perform and set a new price target of $3.00 from $6.00 previously

    11/6/25 6:47:40 AM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    $HNST
    $LUNG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Science &Techn. Officer Radhakrishnan Srikanth sold $22,325 worth of shares (14,497 units at $1.54), decreasing direct ownership by 4% to 331,239 units (SEC Form 4) to cover withholding tax

    4 - Pulmonx Corp (0001127537) (Issuer)

    6/3/26 4:18:16 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    GENERAL COUNSEL Lehman David Aaron sold $22,475 worth of shares (14,594 units at $1.54), decreasing direct ownership by 4% to 376,161 units (SEC Form 4) (withholding obligation)

    4 - Pulmonx Corp (0001127537) (Issuer)

    6/3/26 4:17:29 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    CHIEF COMMERCIAL OFFICER Rose Geoffrey Beran sold $12,355 worth of shares (8,023 units at $1.54), decreasing direct ownership by 2% to 457,711 units (SEC Form 4) (for withholding tax)

    4 - Pulmonx Corp (0001127537) (Issuer)

    6/3/26 4:16:42 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    $HNST
    $LUNG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Florin Daniel P bought $71,362 worth of shares (23,321 units at $3.06), increasing direct ownership by 25% to 117,231 units (SEC Form 4)

    4 - Pulmonx Corp (0001127537) (Issuer)

    6/5/25 8:39:08 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Williamson Steven S. bought $97,436 worth of shares (14,245 units at $6.84), increasing direct ownership by 7% to 219,531 units (SEC Form 4)

    4 - Pulmonx Corp (0001127537) (Issuer)

    8/22/24 6:41:17 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    $HNST
    $LUNG
    Leadership Updates

    Live Leadership Updates

    View All

    Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

    REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the appointment of Mehul Joshi as Chief Financial Officer, effective April 3, 2024. He succeeds John McKune, who has served as the Company's Interim Chief Financial Officer since October 10, 2023, and will transition to his prior role as Vice President, Corporate Controller. "Mehul is an exceptionally accomplished financial executive and I am excited to welcome him to our leadership team. His proven track record of leading global finance teams within large, diversified companies makes him

    4/2/24 4:05:00 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

    REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that Glen French will retire as the Company's President and Chief Executive Officer, effective March 15, 2024, following over nine years of service to Pulmonx. Concurrently, the Company announced the appointment of Steve Williamson as President and Chief Executive Officer, and as a member of the Company's Board of Directors, also effective March 15, 2024. Mr. French will serve as a Senior Advisor to Mr. Williamson until May 1, 2024 to ensure a seamless transition and then remain a member of

    2/21/24 4:05:00 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    The Honest Company Announces Appointment of Dorria L. Ball as Chief People Officer

    LOS ANGELES, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The Honest Company, a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care, today announced Dorria L. Ball as the Company's new Chief People Officer (CPO), effective immediately. Ball has served in this role on an interim basis since August of 2023. Reporting directly to Carla Vernón, CEO of The Honest Company, Ball will continue working alongside Honest's executive leadership team and Board of Directors as the leader of the People & Workplace function. "At Honest, we believe that values, business performance, DEI, and

    1/5/24 4:00:00 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    $HNST
    $LUNG
    Financials

    Live finance-specific insights

    View All

    The Honest Company Reports First Quarter 2026 Results

    Delivers Accelerated Revenue Growth, Led by Wipes & Personal Care Achieves Record Gross Margins, Fueled by Powering Honest GrowthReaffirms Full Year 2026 Financial Outlook LOS ANGELES, May 06, 2026 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults, today reported financial results for the three months ended March 31, 2026. First Quarter 2026 Financial Highlights Compared to Prior Year Period: Revenue of $78.1 million decreased 19.7%; Organic Revenue (excluding Powering Honest Growth exits)(1) increased 3.9%Gross margin of 42.6% increased 390 basis poi

    5/6/26 4:05:00 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Pulmonx Reports First Quarter 2026 Financial Results

    REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the first quarter of 2026 ended March 31, 2026. Recent Highlights Achieved worldwide revenue of $20.6 million in the first quarter of 2026, a 9% decrease over the same period last year and a decrease of 12% on a constant currency basisDelivered $13.3 million in U.S. revenue in the first quarter of 2025, representing a 7% year-over-year decreaseDelivered $7.3 million in international revenue in the first quarter of 2026, representing a 12% year-over-year decrease

    4/29/26 4:05:00 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    The Honest Company to Report First Quarter 2026 Financial Results on May 6, 2026

    LOS ANGELES, April 15, 2026 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults, today announced that it will report first quarter 2026 financial results after the market closes on Wednesday, May 6, 2026. The Company will host a conference call and webcast at 1:45pm PT/4:45pm ET on the same day. For those interested in participating in the conference call by phone, please click here and you will be provided with dial-in details directly to your registered email. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ah

    4/15/26 4:05:00 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    $HNST
    $LUNG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pulmonx Corporation

    SC 13G/A - Pulmonx Corp (0001127537) (Subject)

    11/14/24 7:47:49 PM ET
    $LUNG
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Honest Company Inc.

    SC 13G/A - Honest Company, Inc. (0001530979) (Subject)

    11/14/24 6:19:57 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by The Honest Company Inc.

    SC 13G/A - Honest Company, Inc. (0001530979) (Subject)

    11/14/24 5:53:21 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary